Nedaplatin and irinotecan combination therapy is equally effective and less toxic than cisplatin and irinotecan for patients with primary clear cell adenocarcinoma of the ovary and recurrent ovarian carcinoma

Author:                

Publisher: Spandidos Publications

ISSN: 1792-1074

Source: Oncology Letters, Vol.4, Iss.5, 2012-01, pp. : 1017-1022

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content